  | Pirson, S.* , Gautier-Isola, M.* , Baudin, L., Rouaud, L., Vanwynsberghe, A., Deroye, J., Bekisz, S., Gucciardo, F., LEBEAU, A., Buntinx, F., Ivanova, E., Staumont, B., Blacher, S., Gilles, C.* , & Noël, A.*. (27 February 2025). AXL promotes lymphangiogenesis by amplifying VEGF-C-mediated AKT pathway. Cellular and Molecular Life Sciences, 82 (1), 95. doi:10.1007/s00018-024-05542-3  Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Pirson, S., Gautier, M., Baudin, L., Rouaud, L., Vanwynsberghe, A., Deroye, J., Bekisz, S., Gucciardo, F., Lebeau, A., Staumont, B., Blacher, S., Gilles, C., & Noël, A. (05 March 2024). AXL promotes lymphangiogenesis by amplifying VEGF-C-mediated PI3K/AKT pathway [Poster presentation]. Gordon Research Conference and Seminar on Lymphatics, Ventura, United States - California. |
 | Lorquet, S., Chatelain, C., Laterre, M., FUDVOYE, J., SENTERRE, A., Vanwynsberghe, A., DEBERG, M., Gatot, J.-S., Bulk, S., & Harvengt, J. (January 2024). Cas clinique : Mise au point diagnostique d’une discordance de sexe fœtal à l’ère du IPT génomique : illustration clinique et recommandation pratique. Revue Médicale de Liège, 79 (1). Editorial Reviewed verified by ORBi |
Pirson, S., Gautier, M., Baudin, L., Rouaud, L., Vanwynsberghe, A., Deroye, J., Bekisz, S., Gucciardo, F., Lebeau, A., Staumont, B., Blacher, S., Gilles, C., & Noël, A. (14 June 2023). Identification of a new actor involved in lymphangiogenesis processes [Poster presentation]. Lymphatic Forum 2023, Banff, Canada. |
  | Villard, A., Genna, A., Vanwynsberghe, A., & Gilles, C. (20 June 2022). CD44 regulation of Tissue Factor-dependent procoagulant properties: implication for metastasis of breast tumor cells [Poster presentation]. European Association for Cancer Research, Séville, Spain. |
 | Villard, A., Genna, A., Vanwynsberghe, A., & Gilles, C. (09 June 2021). CD44 regulation of Tissue Factor-dependent procoagulant properties: implication for metastasis of breast tumor cells [Poster presentation]. European Association for Cancer Research Virtual Congress. |
 | Villard, A., Vanwynsberghe, A., Genna, A., & Gilles, C. (26 January 2021). An EMT/CD44/TF axis in Circulating Tumour Cells [Poster presentation]. Televie Cancer Seminar. |
Vanwynsberghe, A., Francart, M.-E., Genna, A., Polette, M., & Gilles, C. (24 June 2020). Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis [Poster presentation]. AACR, San Diego (virtual session), United States. |
 | Genna, A.* , Vanwynsberghe, A.* , Villard, A.* , POTTIER, C., Ancel, J., Polette, M., & Gilles, C. (2020). EMT-Associated Heterogeneity in Circulating Tumor Cells : Sticky Friends on the Road to Metastasis. Cancers, 12 (6), 1632. doi:10.3390/cancers12061632 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Francart, M.-E.* , Vanwynsberghe, A.* , Lambert, J., Bourcy, M., Genna, A., Ancel, J., Perez-Boza, J., Noël, A., Birembaut, P., Struman, I., Polette, M., & Gilles, C. (2020). Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis. Oncogene, 18, 3680-3692. doi:10.1038/s41388-020-1244-1 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Vanwynsberghe, A., Genna, A., & Gilles, C. (12 November 2019). Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA and facilitates early metastasis [Poster presentation]. TEMTIA IX (9th International EMT meeting), Kumamoto, Japan. |
Vanwynsberghe, A., Francart, M.-E., Lambert, J., Genna, A., & Gilles, C. (01 February 2019). Vimentin as a potential regulator of EMT-induced Tissue Factor during metastatic progression [Paper presentation]. BACR annual meeting, Antwerpen, Belgium. |
Genna, A., Van Loo, S., Vanwynsberghe, A., Gilet, T., & Gilles, C. (01 February 2019). Characterization of EMT-shifted coagulant CTC [Poster presentation]. BACR annual meeting, Antwerpen, Belgium. |
Genna, A., Van Loo, S., Vanwynsberghe, A., Gilet, T., & Gilles, C. (28 January 2019). Characterization of EMT-shifted coagulant CTC [Poster presentation]. TÉLÉVIE’S RESEARCHERS SEMINAR, Gembloux, Belgium. |
Vanwynsberghe, A., Genna, A., & Gilles, C. (28 January 2019). Targeting a coagulation-EMT axis in early metastasis [Poster presentation]. TÉLÉVIE’S RESEARCHERS SEMINAR, GEMBLOUX, Belgium. |
Vanwynsberghe, A., Francart, M.-E., Lambert, J., & Gilles, C. (03 August 2018). Vimentin as a potential regulator of EMT-induced Tissue Factor during metastatic progression [Poster presentation]. 17th Biennial Congress of the MRS & Young Investigator Satellite Meeting, Princeton, NJ, United States. |
Vanwynsberghe, A., Lambert, J., Francart, M.-E., & Gilles, C. (01 February 2018). Targeting a coagulation-EMT axis in early metastasis [Poster presentation]. Séminaire des chercheurs Télévie 2018, Bruxelles, Belgium. |
Lambert, J., Francart, M.-E., Vanwynsberghe, A., Polette, M., & Gilles, C. (01 February 2018). Implication of Epithelial-to-Mesenchymal Transitions (EMTs) on the formation of fibrin(ogen)-rich vascular nests for Circulating Tumor Cells (CTCs) [Poster presentation]. Séminaire des chercheurs Télévie 2018, Bruxelles, Belgium. |
Lambert, J., Francart, M.-E., Vanwynsberghe, A., Polette, M., & Gilles, C. (27 January 2018). Implication of Epithelial-to-Mesenchymal Transitions (EMTs) on the formation of fibrin(ogen)-rich vascular nests for Circulating Tumor Cells (CTCs) [Poster presentation]. Novel outlooks of omics in cancer research, Liège, Belgium. |
Vanwynsberghe, A., Lambert, J., Francart, M.-E., & Gilles, C. (27 January 2018). EMT-induced TF as a targetable pathway in early metastasis [Paper presentation]. Annual meeting of the Belgian Association of Cancer Research. |
Francart, M.-E., Bourcy, M., Lambert, J., Vanwynsberghe, A., & Gilles, C. (27 January 2018). Regulation of Tissue Factor by Epithelial-to-Mesenchymal Transitions: Impacts for the metastatic progression [Poster presentation]. BACR, Liège, Belgium. |
 | Francart, M.-E., Lambert, J., Vanwynsberghe, A., Thompson, E., Bourcy, M., Polette, M., & Gilles, C. (2018). Epithelial-Mesenchymal Plasticity and Circulating Tumor Cells: Travel Companions to Metastases. Developmental Dynamics, 247 (3), 432-450. doi:10.1002/dvdy.24506 Peer Reviewed verified by ORBi |
Lambert, J., Francart, M.-E., Vanwynsberghe, A., Skrypek, N., Thompson, E. W., Berx, G., Hollier, B., & Gilles, C. (09 December 2017). EMT transcription factors induce tissue factor expression and pro-coagulant properties, supporting early metastasis of circulating tumor cells [Poster presentation]. 8th International Meeting on Epithelial-Mesenchymal Transition, Houston, United States. |
Francart, M.-E., Bourcy, M., Lambert, J., Vanwynsberghe, A., & Gilles, C. (07 December 2017). Regulation of Tissue Factor by Epithelial-to-Mesenchymal Transitions: impacts for the metastatic progression [Poster presentation]. TEMTIA-VII, Houston, United States. |
 | Fernández-Verdejo, R., Vanwynsberghe, A., Hai, T., Deldicque, L., & Francaux, M. (14 October 2017). Activating transcription factor 3 regulates chemokine expression in contracting C2C12 myotubes and in mouse skeletal muscle after eccentric exercise. Biochemical and Biophysical Research Communications, 492 (2), 249-254. doi:10.1016/j.bbrc.2017.08.059 Peer reviewed |
Vanwynsberghe, A., Francart, M.-E., Lambert, J., Skrypek, N., Thompson, E. W., Berx, G., Hollier, B., & Gilles, C. (29 August 2017). EMT transcription factors induce tissue factor expression and pro-coagulant properties, supporting early metastasis of circulating tumor cells [Poster presentation]. LKI Symposium-Liquid Biopsies and Cancer, Leuven, Belgique. |
Francart, M.-E., Bourcy, M., Lambert, J., Vanwynsberghe, A., & Gilles, C. (28 August 2017). Regulation of Tissue Factor by Epithelial-to-Mesenchymal Transitions: impacts for the metastatic progression [Poster presentation]. LKI symposium - Liquid Biopsies and Cancer, Leuven, Belgium. |
Lambert, J., Francart, M.-E., Vanwynsberghe, A., Polette, M., & Gilles, C. (28 August 2017). Implication of Epithelial-to-Mesenchymal Transitions (EMTs) on the formation of fibrin(ogen)-rich vascular nests for Circulating Tumor Cells (CTCs) [Poster presentation]. LKI Symposium, Leuven, Belgium. |
Lambert, J., Francart, M.-E., Vanwynsberghe, A., Polette, M., & Gilles, C. (26 June 2017). Implication of Epithelial-to-Mesenchymal Transitions (EMTs) on the formation of fibrin(ogen)-rich vascular nests for Circulating Tumor Cells (CTCs) [Poster presentation]. EACR-‐AACR-‐SIC Special Conference 2017-‐ « The Challenges of Optimising Immuno and Targeted Therapies: from Cancer Biology to the Clinic », Florence, Italy. |
| Francart, M.-E., Bourcy, M., Lambert, J., Vanwynsberghe, A., & Gilles, C. (25 June 2017). Regulation of Tissue Factor by Epithelial-to-Mesenchymal Transitions: Impacts for the metastatic progression [Poster presentation]. EACR-AACR-SIC Special Conference 2017, Florence, Italy. |
 | Fernández-Verdejo, R., Vanwynsberghe, A., Essaghir, A., Demoulin, J.-B., Hai, T., Deldicque, L., & Francaux, M. (2017). Activating transcription factor 3 attenuates chemokine and cytokine expression in mouse skeletal muscle after exercise and facilitates molecular adaptation to endurance training. FASEB Journal, 31 (2), 840-851. doi:10.1096/fj.201600987R Peer Reviewed verified by ORBi |